Walle, I. V. D., Bracke, L., Olesen, H. G., Bragt, T. V., Cadour, S., Decker, P. D., Ciurlia, G., Pannecoucke, E., Persson, E. K., Steen, O. V. D., Leng, X., Andersen, G. R., Gandini, D., Hack, C. E. (2025). Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart. Nature Communications. https://doi.org/10.1038/s41467-025-62925-1